Page last updated: 2024-10-18

dalteparin and Diabetes Mellitus, Type 2

dalteparin has been researched along with Diabetes Mellitus, Type 2 in 9 studies

Dalteparin: A low-molecular-weight fragment of heparin, prepared by nitrous acid depolymerization of porcine mucosal heparin. The mean molecular weight is 4000-6000 daltons. It is used therapeutically as an antithrombotic agent. (From Merck Index, 11th ed)

Diabetes Mellitus, Type 2: A subclass of DIABETES MELLITUS that is not INSULIN-responsive or dependent (NIDDM). It is characterized initially by INSULIN RESISTANCE and HYPERINSULINEMIA; and eventually by GLUCOSE INTOLERANCE; HYPERGLYCEMIA; and overt diabetes. Type II diabetes mellitus is no longer considered a disease exclusively found in adults. Patients seldom develop KETOSIS but often exhibit OBESITY.

Research Excerpts

ExcerptRelevanceReference
"A chest CT scan showed an acute type B aortic dissection (ATBAD) and bilateral lung involvement with ground-glass opacity, compatible with interstitial pneumonia."1.56An infection-oriented approach for thoracic endovascular aortic repair in a SARS-CoV-2 positive patient. A case report. ( Ferrari, SA; Muzzarelli, L; Piconi, S; Rossi, G; Sommaruga, S, 2020)

Research

Studies (9)

TimeframeStudies, this research(%)All Research%
pre-19900 (0.00)18.7374
1990's2 (22.22)18.2507
2000's4 (44.44)29.6817
2010's2 (22.22)24.3611
2020's1 (11.11)2.80

Authors

AuthorsStudies
Biesek, D1
Ksiazkiewicz, B1
Wanat-Słupska, E1
Yang, C1
Wu, T1
Huang, C1
Rossi, G1
Ferrari, SA1
Sommaruga, S1
Muzzarelli, L1
Piconi, S1
Roffi, M1
Eberli, FR1
Nwachukwu, U1
Georgescu, A1
Alexandru, N1
Nemecz, M1
Titorencu, I1
Popov, D1
Chazova, IE1
Mychka, VB1
Mamyrbaeva, KM1
Gornostaev, VV1
Dvoskina, IM1
Sergienko, VB1
Grozovski, ES1
Cohen, JD1
Grunberg, G1
Keslin, J1
Gassner, S1
Kalani, M1
Apelqvist, J1
Blombäck, M1
Brismar, K1
Eliasson, B1
Eriksson, JW1
Fagrell, B1
Hamsten, A1
Torffvit, O1
Jörneskog, G1

Reviews

1 review available for dalteparin and Diabetes Mellitus, Type 2

ArticleYear
Diabetes and acute coronary syndromes.
    Best practice & research. Clinical endocrinology & metabolism, 2009, Volume: 23, Issue:3

    Topics: Acute Coronary Syndrome; Anticoagulants; Aspirin; Blood Glucose; Clopidogrel; Diabetes Mellitus; Dia

2009

Trials

1 trial available for dalteparin and Diabetes Mellitus, Type 2

ArticleYear
Effect of dalteparin on healing of chronic foot ulcers in diabetic patients with peripheral arterial occlusive disease: a prospective, randomized, double-blind, placebo-controlled study.
    Diabetes care, 2003, Volume: 26, Issue:9

    Topics: Age of Onset; Aged; Aged, 80 and over; Arterial Occlusive Diseases; Body Mass Index; Dalteparin; Dia

2003

Other Studies

7 other studies available for dalteparin and Diabetes Mellitus, Type 2

ArticleYear
[Conus medullaris and cauda equina infarct in the course of thrombosis of deep veins of lower extremities].
    Polski merkuriusz lekarski : organ Polskiego Towarzystwa Lekarskiego, 2004, Volume: 17, Issue:99

    Topics: Diabetes Mellitus, Type 2; Fibrinolytic Agents; Humans; Ischemia; Male; Middle Aged; Nadroparin; Pol

2004
Low molecular weight heparin reduces triglyceride, VLDL and cholesterol/HDL levels in hyperlipidemic diabetic patients on hemodialysis.
    American journal of nephrology, 1998, Volume: 18, Issue:5

    Topics: Adult; Aged; Anticoagulants; Cholesterol; Cholesterol, HDL; Cholesterol, VLDL; Cross-Over Studies; D

1998
An infection-oriented approach for thoracic endovascular aortic repair in a SARS-CoV-2 positive patient. A case report.
    Annali italiani di chirurgia, 2020, Volume: 91

    Topics: Anesthesia, Local; Antibiotic Prophylaxis; Anticoagulants; Antiviral Agents; Aortic Aneurysm, Thorac

2020
Health trends.
    The Consultant pharmacist : the journal of the American Society of Consultant Pharmacists, 2010, Volume: 25, Issue:4

    Topics: Adolescent; Adult; Age Factors; Aged; Aged, 80 and over; Blood Glucose; Bone Density Conservation Ag

2010
Enoxaparin reduces adrenergic contraction of resistance arterioles in aging and in aging associated with diabetes via engagement of MAP kinase pathway.
    Blood coagulation & fibrinolysis : an international journal in haemostasis and thrombosis, 2011, Volume: 22, Issue:4

    Topics: Adrenergic Agents; Aging; Animals; Arterioles; Cricetinae; Diabetes Mellitus, Experimental; Diabetes

2011
[Cerebrovascular complications in metabolic syndrome: possible approaches to decrease risk].
    Terapevticheskii arkhiv, 2004, Volume: 76, Issue:6

    Topics: Adult; Anticoagulants; Blood Glucose; Blood Pressure; Body Mass Index; Brain; C-Peptide; Cardiovascu

2004
Heparin-induced thrombocytopenia and paradoxical venous thromboses.
    Israel journal of medical sciences, 1993, Volume: 29, Issue:8

    Topics: Aged; Axillary Vein; Coronary Disease; Diabetes Mellitus, Type 2; Enoxaparin; Female; Femoral Vein;

1993